Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis
- PMID: 28123463
- PMCID: PMC5244977
- DOI: 10.3892/etm.2016.3952
Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis
Abstract
Hepatocarcinogenesis is a prerequisite to hepatocellular carcinoma (HCC), which is one of the most common cancers among humans. Therefore, it is important to search for agents that protect against hepatocarcinogenesis. The present study aimed to investigate the protective effects of a combination of taurine and curcumin against experimental hepatocarcinogenesis induced by diethyl nitrosamine (DENA) in a rat model. A total of 100 rats were divided into eight groups. Eight weeks following DENA injection and treatment with curcumin and taurine, the rats were sacrificed to obtain blood and hepatic tissue samples for the evaluation of various markers and histopathological observations. Serum levels of interleukin-2 (IL-2), interferon-γ (IFN-γ), α-fetoprotein (AFP) and α-L-fucosidase (AFU) were determined. Rats injected with DENA for eight weeks showed a high percentage of malignant changes in hepatic tissues, as well as a significant increases in the serum levels of AFP and AFU and significant reductions in the serum levels of IL-2 and IFN-γ. Treatment with curcumin and taurine markedly reduced the extent of malignant changes in the rat liver tissues, with their liver tissues showing patterns similar to that of the normal control rats. In addition, this combination resulted in normal serum levels of IL-2, IFN-γ, AFP and AFU. The results of the present study suggested that a combination of curcumin and taurine may be a novel prophylactic agent against hepatocarcinogenesis in high-risk groups exposed to chemical hepatocarcinogens.
Keywords: curcumin; interferon-γ; interleukin-2; rat hepatocarcinogenesis; taurine; α-L-fucosidase; α-fetoprotein.
Figures








Similar articles
-
Hepatoprotective effects of curcumin against diethyl nitrosamine induced hepatotoxicity in albino rats.Asian Pac J Cancer Prev. 2015;16(1):103-8. doi: 10.7314/apjcp.2015.16.1.103. Asian Pac J Cancer Prev. 2015. PMID: 25640336
-
Altered Cell to Cell Communication, Autophagy and Mitochondrial Dysfunction in a Model of Hepatocellular Carcinoma: Potential Protective Effects of Curcumin and Stem Cell Therapy.Asian Pac J Cancer Prev. 2015;16(18):8271-9. doi: 10.7314/apjcp.2015.16.18.8271. Asian Pac J Cancer Prev. 2015. PMID: 26745072
-
Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma.Clin Exp Med. 2019 Feb;19(1):115-120. doi: 10.1007/s10238-018-0537-y. Epub 2018 Nov 20. Clin Exp Med. 2019. PMID: 30460419
-
Potential impact of curcumin and taurine on human hepatoma cells using Huh-7 cell line.Clin Biochem. 2012 Nov;45(16-17):1519-21. doi: 10.1016/j.clinbiochem.2012.06.032. Epub 2012 Jul 6. Clin Biochem. 2012. PMID: 22776359
-
Chemosensitizing effect of Alpinia officinarum rhizome extract in cisplatin-treated rats with hepatocellular carcinoma.Biomed Pharmacother. 2018 May;101:710-718. doi: 10.1016/j.biopha.2018.02.128. Epub 2018 Mar 22. Biomed Pharmacother. 2018. PMID: 29524879
Cited by
-
Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer.Exp Ther Med. 2020 Nov;20(5):18. doi: 10.3892/etm.2020.9145. Epub 2020 Aug 26. Exp Ther Med. 2020. PMID: 32934683 Free PMC article.
-
The potential immuno-stimulating effect of curcumin, piperine, and taurine combination in hepatocellular carcinoma; a pilot study.Discov Oncol. 2023 Sep 13;14(1):169. doi: 10.1007/s12672-023-00785-1. Discov Oncol. 2023. PMID: 37704828 Free PMC article.
-
A biochemical, theoretical and immunohistochemical study comparing the therapeutic efficacy of curcumin and taurine on T-2 toxin induced hepatotoxicity in rats.Front Mol Biosci. 2023 May 4;10:1172403. doi: 10.3389/fmolb.2023.1172403. eCollection 2023. Front Mol Biosci. 2023. PMID: 37214337 Free PMC article.
-
Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).Int J Oncol. 2020 Sep;57(3):631-664. doi: 10.3892/ijo.2020.5100. Epub 2020 Jul 14. Int J Oncol. 2020. PMID: 32705269 Free PMC article. Review.
-
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects.Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3007-3013. doi: 10.31557/APJCP.2019.20.10.3007. Asian Pac J Cancer Prev. 2019. PMID: 31653148 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources